THE POTENTIAL ENVIRONMENTAL CONSEQUENCES OF GENETIC ENGINEERING
United States. Congress. Senate. Committee on Environment and Public Works. Subcommittee on Toxic Substances and Environmental Oversight
Washington, DC: U.S. Government Printing Office [GPO], 1984. 204 p.
Showing items related by title, author, creator and subject.
The Commissioner's Report of Investigation of Charges From Joint Hearings, Subcommittee on Health, Labor and Public Welfare Committee, Subcommittee on Administrative Practice and Procedure, Judiciary Committee, United States Senate, August 15-16, 1974 Unknown author (United States. Food and Drug Administration [FDA], 1975)
Gene therapy: Is there oversight for patient safety? Hearing before the Subcommittee on Public Health of the Committee on Health, Education, Labor, and Pensions. U.S. Senate, 106th Congress, 2nd Session. February 2, 2000. 129 p. United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Subcommittee on Public Health (2000)
Stem Cell Research: Hearings before a Subcommittee of the Committee on Appropriations, United States Senate, One Hundred Fifth Congress, Second Session. Special Hearing. December 2, 1998, January 12, 1999, and January 26, 1999 [S. Hrg. 105-939] United States. Congress. Senate. Committee on Appropriations. Subcommittee on Departments of Labor, Health and Human Services, and Education, and Related Agencies (1999)